When Serbia’s broadcast regulator REM awarded a cable licence to Tanjug TV in 2021, the regulator’s head failed to reveal she ...
BofA raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $567 from $555 and keeps a Buy rating on the shares. After having ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback